Logo image of C5H.I

CAIRN HOMES PLC (C5H.I) Stock Fundamental Analysis

Europe - DUB:C5H - IE00BWY4ZF18 - Common Stock

1.93 EUR
+0.03 (+1.69%)
Last: 10/22/2025, 5:26:22 PM
Fundamental Rating

6

Taking everything into account, C5H scores 6 out of 10 in our fundamental rating. C5H was compared to 34 industry peers in the Household Durables industry. While C5H belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. C5H has a decent growth rate and is not valued too expensively. C5H also has an excellent dividend rating. With these ratings, C5H could be worth investigating further for dividend investing!.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

C5H had positive earnings in the past year.
In the past year C5H has reported a negative cash flow from operations.
Each year in the past 5 years C5H has been profitable.
Of the past 5 years C5H 4 years had a positive operating cash flow.
C5H.I Yearly Net Income VS EBIT VS OCF VS FCFC5H.I Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200M -400M

1.2 Ratios

C5H has a Return On Assets of 7.73%. This is amongst the best in the industry. C5H outperforms 85.29% of its industry peers.
C5H has a Return On Equity of 13.01%. This is in the better half of the industry: C5H outperforms 76.47% of its industry peers.
C5H has a Return On Invested Capital of 10.12%. This is in the better half of the industry: C5H outperforms 79.41% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for C5H is in line with the industry average of 10.91%.
Industry RankSector Rank
ROA 7.73%
ROE 13.01%
ROIC 10.12%
ROA(3y)8.93%
ROA(5y)6.46%
ROE(3y)12.39%
ROE(5y)8.88%
ROIC(3y)11.22%
ROIC(5y)8.33%
C5H.I Yearly ROA, ROE, ROICC5H.I Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 15

1.3 Margins

C5H has a Profit Margin of 12.77%. This is amongst the best in the industry. C5H outperforms 91.18% of its industry peers.
In the last couple of years the Profit Margin of C5H has grown nicely.
C5H has a better Operating Margin (16.87%) than 91.18% of its industry peers.
C5H's Operating Margin has improved in the last couple of years.
C5H has a worse Gross Margin (21.81%) than 76.47% of its industry peers.
C5H's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 16.87%
PM (TTM) 12.77%
GM 21.81%
OM growth 3Y8.2%
OM growth 5Y2.23%
PM growth 3Y9.36%
PM growth 5Y2.53%
GM growth 3Y3.19%
GM growth 5Y2.1%
C5H.I Yearly Profit, Operating, Gross MarginsC5H.I Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800 -1K

6

2. Health

2.1 Basic Checks

C5H has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for C5H has been reduced compared to 1 year ago.
The number of shares outstanding for C5H has been reduced compared to 5 years ago.
Compared to 1 year ago, C5H has a worse debt to assets ratio.
C5H.I Yearly Shares OutstandingC5H.I Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M
C5H.I Yearly Total Debt VS Total AssetsC5H.I Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

An Altman-Z score of 3.94 indicates that C5H is not in any danger for bankruptcy at the moment.
C5H has a better Altman-Z score (3.94) than 85.29% of its industry peers.
A Debt/Equity ratio of 0.45 indicates that C5H is not too dependend on debt financing.
With a Debt to Equity ratio value of 0.45, C5H perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF N/A
Altman-Z 3.94
ROIC/WACC1.35
WACC7.5%
C5H.I Yearly LT Debt VS Equity VS FCFC5H.I Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M 600M

2.3 Liquidity

C5H has a Current Ratio of 7.09. This indicates that C5H is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 7.09, C5H belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
A Quick Ratio of 1.28 indicates that C5H should not have too much problems paying its short term obligations.
C5H has a better Quick ratio (1.28) than 76.47% of its industry peers.
Industry RankSector Rank
Current Ratio 7.09
Quick Ratio 1.28
C5H.I Yearly Current Assets VS Current LiabilitesC5H.I Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

4

3. Growth

3.1 Past

C5H shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -7.00%.
The Earnings Per Share has been growing by 20.48% on average over the past years. This is a very strong growth
Looking at the last year, C5H shows a decrease in Revenue. The Revenue has decreased by -4.33% in the last year.
The Revenue has been growing by 14.59% on average over the past years. This is quite good.
EPS 1Y (TTM)-7%
EPS 3Y43.61%
EPS 5Y20.48%
EPS Q2Q%-29.5%
Revenue 1Y (TTM)-4.33%
Revenue growth 3Y26.58%
Revenue growth 5Y14.59%
Sales Q2Q%-22.31%

3.2 Future

Based on estimates for the next years, C5H will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.19% on average per year.
Based on estimates for the next years, C5H will show a small growth in Revenue. The Revenue will grow by 6.57% on average per year.
EPS Next Y13.52%
EPS Next 2Y11.89%
EPS Next 3Y9.19%
EPS Next 5YN/A
Revenue Next Year10.5%
Revenue Next 2Y9.34%
Revenue Next 3Y6.57%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
C5H.I Yearly Revenue VS EstimatesC5H.I Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
C5H.I Yearly EPS VS EstimatesC5H.I Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.05 0.1 0.15 0.2

5

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 12.06, C5H is valued correctly.
Based on the Price/Earnings ratio, C5H is valued a bit cheaper than 73.53% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.57, C5H is valued rather cheaply.
A Price/Forward Earnings ratio of 8.32 indicates a reasonable valuation of C5H.
73.53% of the companies in the same industry are more expensive than C5H, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 23.09. C5H is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 12.06
Fwd PE 8.32
C5H.I Price Earnings VS Forward Price EarningsC5H.I Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

C5H's Enterprise Value to EBITDA is on the same level as the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 11.2
C5H.I Per share dataC5H.I EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6 0.8 1

4.3 Compensation for Growth

C5H's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
C5H has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)0.89
PEG (5Y)0.59
EPS Next 2Y11.89%
EPS Next 3Y9.19%

7

5. Dividend

5.1 Amount

C5H has a Yearly Dividend Yield of 4.39%, which is a nice return.
Compared to an average industry Dividend Yield of 5.04, C5H pays a bit more dividend than its industry peers.
C5H's Dividend Yield is rather good when compared to the S&P500 average which is at 2.32.
Industry RankSector Rank
Dividend Yield 4.39%

5.2 History

On average, the dividend of C5H grows each year by 23.30%, which is quite nice.
Dividend Growth(5Y)23.3%
Div Incr Years3
Div Non Decr Years3
C5H.I Yearly Dividends per shareC5H.I Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.02 0.04 0.06

5.3 Sustainability

C5H pays out 51.93% of its income as dividend. This is a bit on the high side, but may be sustainable.
C5H's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP51.93%
EPS Next 2Y11.89%
EPS Next 3Y9.19%
C5H.I Yearly Income VS Free CF VS DividendC5H.I Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200M -400M
C5H.I Dividend Payout.C5H.I Dividend Payout, showing the Payout Ratio.C5H.I Dividend Payout.PayoutRetained Earnings

CAIRN HOMES PLC

DUB:C5H (10/22/2025, 5:26:22 PM)

1.93

+0.03 (+1.69%)

Chartmill FA Rating
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryHousehold Durables
Earnings (Last)09-03 2025-09-03
Earnings (Next)02-25 2026-02-25/amc
Inst Owners80.15%
Inst Owner ChangeN/A
Ins Owners3.77%
Ins Owner ChangeN/A
Market Cap1.21B
Revenue(TTM)778.20M
Net Income(TTM)99.37M
Analysts83.64
Price Target2.51 (30.05%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.39%
Yearly Dividend0.07
Dividend Growth(5Y)23.3%
DP51.93%
Div Incr Years3
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.41%
PT rev (3m)0.3%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)1.66%
EPS NY rev (3m)2%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.29%
Revenue NY rev (3m)-0.22%
Valuation
Industry RankSector Rank
PE 12.06
Fwd PE 8.32
P/S 1.55
P/FCF N/A
P/OCF N/A
P/B 1.58
P/tB 1.59
EV/EBITDA 11.2
EPS(TTM)0.16
EY8.29%
EPS(NY)0.23
Fwd EY12.03%
FCF(TTM)-0.06
FCFYN/A
OCF(TTM)-0.05
OCFYN/A
SpS1.24
BVpS1.22
TBVpS1.21
PEG (NY)0.89
PEG (5Y)0.59
Graham Number2.1
Profitability
Industry RankSector Rank
ROA 7.73%
ROE 13.01%
ROCE 11.85%
ROIC 10.12%
ROICexc 10.54%
ROICexgc 10.58%
OM 16.87%
PM (TTM) 12.77%
GM 21.81%
FCFM N/A
ROA(3y)8.93%
ROA(5y)6.46%
ROE(3y)12.39%
ROE(5y)8.88%
ROIC(3y)11.22%
ROIC(5y)8.33%
ROICexc(3y)11.53%
ROICexc(5y)8.59%
ROICexgc(3y)11.58%
ROICexgc(5y)8.63%
ROCE(3y)13.13%
ROCE(5y)9.75%
ROICexgc growth 3Y32.35%
ROICexgc growth 5Y16.05%
ROICexc growth 3Y32.21%
ROICexc growth 5Y15.96%
OM growth 3Y8.2%
OM growth 5Y2.23%
PM growth 3Y9.36%
PM growth 5Y2.53%
GM growth 3Y3.19%
GM growth 5Y2.1%
F-Score2
Asset Turnover0.61
Health
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF N/A
Debt/EBITDA 2.55
Cap/Depr 127.6%
Cap/Sales 0.45%
Interest Coverage 11.65
Cash Conversion N/A
Profit Quality N/A
Current Ratio 7.09
Quick Ratio 1.28
Altman-Z 3.94
F-Score2
WACC7.5%
ROIC/WACC1.35
Cap/Depr(3y)261.68%
Cap/Depr(5y)199.51%
Cap/Sales(3y)0.79%
Cap/Sales(5y)0.56%
Profit Quality(3y)113.52%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-7%
EPS 3Y43.61%
EPS 5Y20.48%
EPS Q2Q%-29.5%
EPS Next Y13.52%
EPS Next 2Y11.89%
EPS Next 3Y9.19%
EPS Next 5YN/A
Revenue 1Y (TTM)-4.33%
Revenue growth 3Y26.58%
Revenue growth 5Y14.59%
Sales Q2Q%-22.31%
Revenue Next Year10.5%
Revenue Next 2Y9.34%
Revenue Next 3Y6.57%
Revenue Next 5YN/A
EBIT growth 1Y-9.57%
EBIT growth 3Y36.95%
EBIT growth 5Y17.14%
EBIT Next Year10.23%
EBIT Next 3Y6.75%
EBIT Next 5YN/A
FCF growth 1Y-144.37%
FCF growth 3Y14.39%
FCF growth 5Y5.88%
OCF growth 1Y-137.25%
OCF growth 3Y15.01%
OCF growth 5Y6.31%